文献速递慢性肾脏病遗传性与小管间质肾病

携带蛋白截短型PKD1突变的常染色体显性多囊肾病患者也可表现为轻度肾病

Patients with Protein-Truncating PKD1 Mutations and Mild ADPKD.
PubMed 文献 · Clin J Am Soc Nephrol · 2021-02-18

研究基于多伦多遗传流行病学研究,对487例具有典型ADPKD影像学表现且完成PKD1/PKD2测序的患者进行分析,发现174例蛋白截短型PKD1突变患者中32例(18%)按Mayo影像分类1A-1B为轻度病变;多变量分析显示其病变程度与PKD2突变轻度患者相似,且多数有家族史并存在显著家族内变异。

要点

  • 蛋白截短型PKD1突变患者中18%影像学表现为轻度ADPKD。
  • 该轻度表型与PKD2突变且Mayo影像1A-1B患者相似。
  • 轻度患者多有家族史且家族内病变差异显著。

核心结论

  • 尽管蛋白截短型PKD1突变是最严重突变类型,仍有18%患者临床和影像评估为轻度病变。

研究设计与样本

  • 来自多伦多遗传流行病学研究,487例具有典型ADPKD影像模式且完成PKD1和PKD2测序的患者。

主要发现

  • 174例典型影像且蛋白截短型PKD1突变患者中32例(18%)为Mayo影像分类1A-1B轻度病变。
  • 多变量分析显示这些轻度患者与PKD2突变且Mayo影像1A-1B患者病变程度相似。
  • 多数轻度蛋白截短型PKD1突变患者有ADPKD家族史并显示显著家族内病变变异。

关键数值与推荐

  • 使用基于年龄和身高调整总肾体积的Mayo影像分类评估囊性病变严重程度,1A或1B类作为轻度病变替代定义。

临床怎么用

  • 临床遇到蛋白截短型PKD1突变患者时不应一概视为必然严重,需结合影像学评估病变程度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Progression of autosomal dominant polycystic kidney disease (ADPKD) is highly variable. On average, protein-truncating PKD1 mutations are associated with the most severe kidney disease among all mutation classes. Here, we report that patients with protein-truncating PKD1 mutations may also have mild kidney disease, a finding not previously well recognized. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: From the extended Toronto Genetic Epidemiologic Study of Polycystic Kidney Disease, 487 patients had PKD1 and PKD2 sequencing and typical ADPKD imaging patterns by magnetic resonance imaging or computed tomography. Mayo Clinic Imaging Classification on the basis of age- and height-adjusted total kidney volume was used to assess their cystic disease severity; classes 1A or 1B were used as a proxy to define mild disease. Multivariable linear regression was performed to test the effects of age, sex, and mutation classes on log-transformed height-adjusted total kidney volume and eGFR. RESULTS: Among 174 study patients with typical imaging patterns and protein-truncating PKD1 mutations, 32 (18%) were found to have mild disease on the basis of imaging results (i.e., Mayo Clinic Imaging class 1A-1B), with their mutations spanning the entire gene. By multivariable analyses of age, sex, and mutation class, they displayed mild disease similar to patients with PKD2 mutations and Mayo Clinic Imaging class 1A-1B. Most of these mildly affected patients with protein-truncating PKD1 mutations reported a positive family history of ADPKD in preceding generations and displayed significant intrafamilial disease variability. CONCLUSIONS: Despite having the most severe mutation class, 18% of patients with protein-truncating PKD1 mutations had mild disease on the basis of clinical and imaging assessment. PODCAST: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2021_02_18_CJN11100720_final.mp3.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Lanktree MB, Guiard E, Akbari P, et al. Patients with Protein-Truncating PKD1 Mutations and Mild ADPKD. Clin J Am Soc Nephrol. 2021. PMID: 33602752. doi:10.2215/CJN.11100720

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。